Notably, several variants of SLC13A5 epilepsy have mutations in the sodium-binding site of NaCT, suggesting that sodium binding deficiency causes impaired citrate transport [7]. This evidence concerns the gene SLC13A5 and hyperinsulinemic hypoglycemia, familial, 4.